Send us Feedback

JOHNSON & JOHNSON (JNJ)
Analysis
Data
Financials
Revenue by Geography    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004		 31-DEC
2005		 31-DEC
2006		 31-DEC
2007		 31-DEC
2008		 newer
Revenue - Western Hemisphere excluding US 2.59B 3.09B 3.54B 4.68B 5.17B
Revenue - Asia, Pacific, Africa 5.84B 6.86B 7.22B 8.33B 9.48B
Revenue - US 27.8B 28.4B 29.8B 32.4B 32.3B
Total Revenue 47.3B 50.5B 53.3B 61.1B 63.7B
Revenue by Segment    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004		 31-DEC
2005		 31-DEC
2006		 31-DEC
2007		 31-DEC
2008		 newer
Revenue - Skin Care 2.14B 2.40B 2.63B 3.05B 3.38B
Revenue - Depuy 3.42B 3.85B 4.11B 4.59B 4.99B
Revenue - LIFESCAN 1.70B 1.91B 0 0 0
Revenue - Hormonal Contraceptives 1.28B 1.14B 0 0 0
Revenue - Ethicon Endo-Surgery 5.69B 6.20B 6.60B 7.44B 8.13B
Revenue - Cordis 3.21B 3.98B 4.09B 3.42B 3.13B
Revenue - Diabetes Care 0 0 2.07B 2.37B 2.54B
Revenue - Vision Care 1.53B 1.69B 1.88B 2.21B 2.50B
Revenue - Ortho-Clinical Diagnostics 1.27B 1.41B 1.54B 1.71B 1.84B
Revenue - Remicade 2.15B 2.54B 3.01B 3.33B 3.75B
Revenue - Topamax 1.41B 1.68B 2.03B 2.45B 2.73B
Revenue - Procrit 3.59B 3.32B 3.18B 2.88B 2.46B
Revenue - Risperdal 3.05B 3.55B 3.33B 3.42B 2.13B
Revenue - Levaquin 1.30B 1.49B 1.53B 1.65B 1.59B
Revenue - Risperdal Consta 0 0 849M 1.13B 1.31B
Revenue - Concerta 0 0 930M 1.03B 1.25B
Revenue - Aciphex 1.12B 1.17B 1.24B 1.36B 1.16B
Revenue - Duragesic 2.08B 1.58B 1.29B 1.16B 1.04B
Revenue - OTC Pharmaceuticals & Nutritionals 2.40B 2.68B 2.74B 5.14B 5.89B
Revenue - Baby Care 1.45B 1.56B 1.74B 1.98B 2.21B
Revenue - Women's Health 1.47B 1.57B 1.67B 1.81B 1.91B
Revenue - Oral Care 0 0 406M 1.49B 1.62B
Revenue - Wound Care 0 0 587M 1.02B 1.03B
Total Revenue 47.3B 50.5B 53.3B 61.1B 63.7B
 
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki